Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

0.0227
0.0000
Volume:- -
Turnover:- -
Market Cap:- -
PE:- -
High:0.0227
Open:0.0227
Low:0.0227
Close:0.0227
52wk High:0.0390
52wk Low:0.0033
Shares:- -
Float Shares:- -
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 20, 2023

Correspondence

Form CORRESP - Correspondence
Nov 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 28, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]